질트리코모나스질염의 Ornidazole 1gm 1일요법에 대한 임상적 평가 = Clinical Evaluation of a Single Day Therapy with Ornidazole 1gm in vaginal trichomoniasis

국문 초록 (Abstract)

1976년 5월부터 동년 7월까지 서울의과대학부속병원산부인과 외래환자중에서 질트리코모나스질염 35명에 대하여 Ornidazole(Tiberal) 1gm 1일요법으로 다음과 같은 성적을 얻었다. 1) 치료성적은 92.6%이었다. 2) 약의 부작용은 전연 인정할 수 없었다. 3) 약의 독성도 전연 인정할 수 없었다. 따라서 Ornidazole 1gm 1일요법은 질트리코모나스질염늬 치료에 있어서 안전하고 우수 한 약제로 판단되었다.

다국어 초록 (Multilingual Abstract)

Previously we had tested a single day therapy with Ornidazole 2 gm in vaginal trichomniasis, in which side effect of dizziness was somewhat troublesome. Hence it was suggested that a lower dose would have adequate trichomocidal effect, but minimal side effects. In this study, ornidazole 1gm was tested in 27 women with vaginal trichomoniasis at Seoul National university Hospital during the period from May to july, 1976. To all patients and their husbands, oridazole 0.5gm was ad,omostered twoce a somg;e dau amd a vagomal tablet 0.5gm was inserted in women. We used Roiron-pattner medium and obtained the following results. 1. The cure rate 1 week later after administration of the drug was 92.6%. 2. Side effects or toxicity of the drug was noticed in none of the patients. It was suggested that a single day tharapy with ornidazole 1gm was effective and well tolerated in the treatment of vaginal trichomoniases.